Sunday, October 26, 2014 10:56:31 AM
~ BMSN = NO Substantial News expected for..MONTHS!..
RGBP (58% owned by BMSN)
Latest Hema News
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107364201
"preclinical safety >>>experiments that need to be conducted before the clinical trial<<< is initiated"
These tests will take at LEAST another 6 weeks++!! - to - 6 months!..++!!
---
Latest dCellVax News
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107360147
Just~a~Submission!!
...well this means 30 days until the FDA gives an actual IND #,, if then,, but we will say they get it,,, so then another 30 days for the FDA (Remember this is the Gov'n't ) to give a thumbs up or wait another 30 days, and then another 30 days, and then another 30 day,, etc etc to 1 3/4 yrs like they have done for the Hema IND!!!
---
Basically RGBP has NOTHING in the Pipeline to be excited about until the week of Dec 8th...if FrRreaking then!!!!!!
___________
As always,, the above Post is "Just My Opinion!"
RGBP (58% owned by BMSN)
Latest Hema News
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107364201
"preclinical safety >>>experiments that need to be conducted before the clinical trial<<< is initiated"
These tests will take at LEAST another 6 weeks++!! - to - 6 months!..++!!
---
Latest dCellVax News
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=107360147
Just~a~Submission!!
...well this means 30 days until the FDA gives an actual IND #,, if then,, but we will say they get it,,, so then another 30 days for the FDA (Remember this is the Gov'n't
) to give a thumbs up or wait another 30 days, and then another 30 days, and then another 30 day,, etc etc to 1 3/4 yrs like they have done for the Hema IND!!! ---
Basically RGBP has NOTHING in the Pipeline to be excited about until the week of Dec 8th...if FrRreaking then!!!!!!
___________
As always,, the above Post is "Just My Opinion!"
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
